Investigation of the Association between COVID 19 Infection, Gastrointestinal Manifestations, Parasitic Diseases and Antiparasitic Treatment: An Electronic Data Compilation
Hamed, A., Elsebaie, E., Shaheen, H., Mahfouz, A., Hasan, M., Abdeltawab, M. (2022). Investigation of the Association between COVID 19 Infection, Gastrointestinal Manifestations, Parasitic Diseases and Antiparasitic Treatment: An Electronic Data Compilation. EKB Journal Management System, 14(1), 85-99. doi: 10.21608/eajbsg.2022.226672
Alshaimaa M. Hamed; Eman H. Elsebaie; Hoda A.A. Shaheen; Amal Mahfouz; Marwa D.A. Hasan; Magda S. Abdeltawab. "Investigation of the Association between COVID 19 Infection, Gastrointestinal Manifestations, Parasitic Diseases and Antiparasitic Treatment: An Electronic Data Compilation". EKB Journal Management System, 14, 1, 2022, 85-99. doi: 10.21608/eajbsg.2022.226672
Hamed, A., Elsebaie, E., Shaheen, H., Mahfouz, A., Hasan, M., Abdeltawab, M. (2022). 'Investigation of the Association between COVID 19 Infection, Gastrointestinal Manifestations, Parasitic Diseases and Antiparasitic Treatment: An Electronic Data Compilation', EKB Journal Management System, 14(1), pp. 85-99. doi: 10.21608/eajbsg.2022.226672
Hamed, A., Elsebaie, E., Shaheen, H., Mahfouz, A., Hasan, M., Abdeltawab, M. Investigation of the Association between COVID 19 Infection, Gastrointestinal Manifestations, Parasitic Diseases and Antiparasitic Treatment: An Electronic Data Compilation. EKB Journal Management System, 2022; 14(1): 85-99. doi: 10.21608/eajbsg.2022.226672

Investigation of the Association between COVID 19 Infection, Gastrointestinal Manifestations, Parasitic Diseases and Antiparasitic Treatment: An Electronic Data Compilation

Egyptian Academic Journal of Biological Sciences, G. Microbiology
Article 8, Volume 14, Issue 1, June 2022, Page 85-99  XML PDF (853.64 K)
Document Type: Original Article
DOI: 10.21608/eajbsg.2022.226672
View on SCiNiTO View on SCiNiTO
Authors
Alshaimaa M. Hamed1; Eman H. Elsebaie2; Hoda A.A. Shaheen3; Amal Mahfouz4; Marwa D.A. Hasan5; Magda S. Abdeltawab6
1Medical Parasitology Department, Faculty of Medicine Cairo University
2Public Health and Community Medicine, Faculty of Medicine, Cairo University, Egypt
3Parasitology Department, Faculty of Medicine for Girls Al-Azhar University, Cairo, Egypt.
4Department of Pharmacology and Toxicology, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt. - Egyptian Drug Authority, Giza, Egypt.
5Family Medicine, Faculty of Medicine, Cairo University, Egypt.
6Medical Parasitology Department, Faculty of Medicine Cairo University.
Abstract
Background: COVID 19 pandemic has posed great challenges to national and international health organizations. This health burden is exaggerated in middle and low-income countries, due to the endemicity of parasitic diseases. Pre-existing parasitic infections and antiparasite drug therapy may modify the host's immune response to infection with SARS-CoV-2 and can attenuate the severity of disease presentation. Methods: A cross-sectional analytical study was done to investigate the possible association between COVID-19 syndrome, gastrointestinal manifestations, parasitic diseases and antiparasitic treatment. A non-probability convenient sampling technique was used to recruit participants, through electronic data collection. Results: The mean age of the survey respondents reporting a positive history of COVID 19 infection was 35.69±12.24 years. Study participants with a positive COVID 19 history have reported a positive history of gastrointestinal disorders in 40.9% of 93 patients responding to that question. Twenty-six out of 95 (27.4%) participants reporting a positive history of COVID 19 also reported a previous history of parasitic infection, while 22 (15.6%) subjects out of 141 individuals with a negative history of COVID 19 infection had a past experience of parasitic infection (P=0.028) Among the parasitic infections stated was amoebiasis, giardiasis and enterobiasis. Conclusions: The higher incidence recorded of parasitic infections among subjects with a positive history of COVID-19 suggests that parasite co-infection 3 may lead predispose to a high incidence of COVID-19, which conflicts with other literature data reporting a protective effect of parasitosis against SARS CoV-2 infection. More extensive survey studies targeting larger populations are of crucial importance, especially in developing countries. 
Keywords
COVID 19- Gastrointestinal Manifestations; electronic data collection and Parasitic Diseases
Statistics
Article View: 226
PDF Download: 229